Subgroup Analysis from Bayesian Perspectives

Identifying the sub-population structures along with the tailored treatments for all groups plays a critical rule for assigning the best available treatment to an individual patient. Subgroup analysis, a key to develop personalized medicine, becomes increasingly important over the past decade. Besides frequentist methods, there are a spectrum of methods developed from Bayesian perspectives to identify subgroups. In this chapter, we provide a comprehensive overview of Bayesian methods and discuss their properties. We further examine empirical performance of the two Bayesian methods via simulation studies and a real data analysis.

[1]  Donglin Zeng,et al.  Estimating Individualized Treatment Rules Using Outcome Weighted Learning , 2012, Journal of the American Statistical Association.

[2]  P. Müller,et al.  Subgroup finding via Bayesian additive regression trees , 2017, Statistics in medicine.

[3]  Yang Liu,et al.  Look before you leap: systematic evaluation of tree-based statistical methods in subgroup identification , 2019, Journal of biopharmaceutical statistics.

[4]  Daisy Zhuo,et al.  Bayesian additive decision trees of biomarker by treatment interactions for predictive biomarker detection and subgroup identification , 2018, Journal of biopharmaceutical statistics.

[5]  Xiaojing Wang,et al.  Bayesian Modeling Using Latent Structures , 2012 .

[6]  I. van Mechelen,et al.  Qualitative interaction trees: a tool to identify qualitative treatment–subgroup interactions , 2014, Statistics in medicine.

[7]  P. Müller,et al.  A Bayesian subgroup analysis using collections of ANOVA models , 2017, Biometrical journal. Biometrische Zeitschrift.

[8]  Eric B. Laber,et al.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data. , 2015, Biometrika.

[9]  J. Berger,et al.  A Bayesian Approach to Subgroup Identification , 2014, Journal of biopharmaceutical statistics.

[10]  W. Loh,et al.  A regression tree approach to identifying subgroups with differential treatment effects , 2014, Statistics in medicine.

[11]  Guosheng Yin,et al.  Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints. , 2013, Contemporary clinical trials.

[12]  Purushottam W. Laud,et al.  A Bayesian subgroup analysis with a zero‐enriched Polya Urn scheme , 2011, Statistics in medicine.

[13]  Michael Branson,et al.  Bayesian models for subgroup analysis in clinical trials , 2011, Clinical trials.

[14]  H. Chipman,et al.  BART: Bayesian Additive Regression Trees , 2008, 0806.3286.

[15]  R. Tibshirani,et al.  Bayesian backfitting (with comments and a rejoinder by the authors , 2000 .

[16]  Lu Tian,et al.  A Simple Method for Detecting Interactions between a Treatment and a Large Number of Covariates , 2012, 1212.2995.

[17]  Tianxi Cai,et al.  A general statistical framework for subgroup identification and comparative treatment scoring , 2017, Biometrics.

[18]  R. Simon,et al.  Bayesian subset analysis. , 1991, Biometrics.

[19]  Xiaogang Su,et al.  Subgroup Analysis via Recursive Partitioning , 2009 .

[20]  I. Lipkovich,et al.  Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations , 2011, Statistics in medicine.

[21]  J. M. Taylor,et al.  Subgroup identification from randomized clinical trial data , 2011, Statistics in medicine.

[22]  B. Carlin,et al.  A Bayesian credible subgroups approach to identifying patient subgroups with positive treatment effects , 2016, Biometrics.